VINORELBINE PIERRE FABRE vinorelbine 30mg (as tartrate) capsule blister pack

البلد: أستراليا

اللغة: الإنجليزية

المصدر: Department of Health (Therapeutic Goods Administration)

العنصر النشط:

vinorelbine tartrate, Quantity: 41.55 mg (Equivalent: vinorelbine, Qty 30 mg)

متاح من:

Pierre Fabre Australia Pty Ltd

الشكل الصيدلاني:

Capsule, soft

تركيب:

Excipient Ingredients: ethanol; purified water; glycerol; macrogol 400; Gelatin; iron oxide red; titanium dioxide; medium chain triglycerides; sorbitol; 1,4-sorbitan; mannitol; hydrogenated starch hydrosylate; ascorbyl palmitate; phosphatidyl choline; dl-alpha-tocopherol; hypromellose; propylene glycol; isopropyl alcohol; aluminium chloride; sodium hydroxide; cochineal

طريقة التعاطي:

Oral

الوحدات في الحزمة:

1 tablet

نوع الوصفة الطبية :

(S4) Prescription Only Medicine

الخصائص العلاجية:

Non-small cell lung cancer: VINORELBINE PIERRE FABRE is indicated for the first line treatment of advanced non-small cell lung cancer, as a single agent or in combination.,Breast cancer: VINORELBINE PIERRE FABRE is indicated for the treatment of advanced breast cancer after failure of standard therapy as a single agent or in combination.

ملخص المنتج:

Visual Identification: Pink soft capsule printed N30.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store at 2 to 8 degrees Celsius

الوضع إذن:

Registered

تاريخ الترخيص:

2005-05-31